Literature DB >> 25526090

Autophagy inhibits oxidative stress and tumor suppressors to exert its dual effect on hepatocarcinogenesis.

Y Tian1, C-F Kuo1, D Sir1, L Wang1, S Govindarajan2, L M Petrovic3, J-H J Ou1.   

Abstract

The role of autophagy in carcinogenesis is controversial and apparently complex. By using mice with hepatocyte-specific knockout of Atg5, a gene essential for autophagy, we longitudinally studied the role of autophagy in hepatocarcinogenesis. We found that impairing autophagy in hepatocytes would induce oxidative stress and DNA damage, followed by the initiation of hepatocarcinogenesis, which could be suppressed by the antioxidant N-acetylcysteine. Interestingly, these mice developed only benign tumors with no hepatocellular carcinoma (HCC), even after the treatment with diethylnitrosamine, which induced HCC in wild-type mice. The inability of mice to develop HCC when autophagy was impaired was associated with the induction of multiple tumor suppressors including p53. Further analysis indicated that the induction of p53 was associated with the DNA-damage response. Tumorigenesis studies using an established liver tumor cell line confirmed a positive role of autophagy in tumorigenesis and a negative role of p53 in this process when autophagy was impaired. Our studies thus demonstrate that autophagy is required to maintain healthy mitochondria and to reduce oxidative stress and DNA damage to prevent the initiation of hepatocarcinogenesis. However, once hepatocarcinogenesis has been initiated, its presence is also required to suppress the expression of tumor suppressors to promote the development of HCC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25526090      PMCID: PMC4423188          DOI: 10.1038/cdd.2014.201

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  29 in total

1.  Induction and excretion of ultraviolet-induced 8-oxo-2'-deoxyguanosine and thymine dimers in vivo: implications for PUVA.

Authors:  M S Cooke; M D Evans; R M Burd; K Patel; A Barnard; J Lunec; P E Hutchinson
Journal:  J Invest Dermatol       Date:  2001-02       Impact factor: 8.551

Review 2.  The Ki-67 protein: from the known and the unknown.

Authors:  T Scholzen; J Gerdes
Journal:  J Cell Physiol       Date:  2000-03       Impact factor: 6.384

3.  Immortal DNA strand cosegregation requires p53/IMPDH-dependent asymmetric self-renewal associated with adult stem cells.

Authors:  Lakshmi Rambhatla; Sumati Ram-Mohan; Jennifer J Cheng; James L Sherley
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

4.  Hepatitis B virus promotes hepatocarcinogenesis in transgenic mice.

Authors:  Yanyan Zheng; Wen-ling Chen; Stan G Louie; T S Benedict Yen; Jing-hsiung James Ou
Journal:  Hepatology       Date:  2007-01       Impact factor: 17.425

5.  Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.

Authors:  M Müller; S Strand; H Hug; E M Heinemann; H Walczak; W J Hofmann; W Stremmel; P H Krammer; P R Galle
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

6.  Induction of autophagy and inhibition of tumorigenesis by beclin 1.

Authors:  X H Liang; S Jackson; M Seaman; K Brown; B Kempkes; H Hibshoosh; B Levine
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

7.  A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.

Authors:  Josep M Llovet; Yingbei Chen; Elisa Wurmbach; Sasan Roayaie; M Isabel Fiel; Myron Schwartz; Swan N Thung; Gregory Khitrov; Weijia Zhang; Augusto Villanueva; Carlo Battiston; Vincenzo Mazzaferro; Jordi Bruix; Samuel Waxman; Scott L Friedman
Journal:  Gastroenterology       Date:  2006-09-19       Impact factor: 22.682

Review 8.  Biomarkers of oxidative damage in human disease.

Authors:  Isabella Dalle-Donne; Ranieri Rossi; Roberto Colombo; Daniela Giustarini; Aldo Milzani
Journal:  Clin Chem       Date:  2006-02-16       Impact factor: 8.327

9.  Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene.

Authors:  Xueping Qu; Jie Yu; Govind Bhagat; Norihiko Furuya; Hanina Hibshoosh; Andrea Troxel; Jeffrey Rosen; Eeva-Liisa Eskelinen; Noboru Mizushima; Yoshinori Ohsumi; Giorgio Cattoretti; Beth Levine
Journal:  J Clin Invest       Date:  2003-11-24       Impact factor: 14.808

10.  Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3.

Authors:  Guillermo Mariño; Natalia Salvador-Montoliu; Antonio Fueyo; Erwin Knecht; Noboru Mizushima; Carlos López-Otín
Journal:  J Biol Chem       Date:  2007-04-17       Impact factor: 5.157

View more
  51 in total

1.  A PINK1-mediated mitophagy pathway decides the fate of tumors-to be benign or malignant?

Authors:  Hui Qian; Xiaojuan Chao; Wen-Xing Ding
Journal:  Autophagy       Date:  2018-02-21       Impact factor: 16.016

Review 2.  Roles of mitochondria in liver cancer stem cells.

Authors:  Ching-Wen Chang; Jeng-Fan Lo; Xin Wei Wang
Journal:  Differentiation       Date:  2019-05-30       Impact factor: 3.880

Review 3.  Autophagy and microRNA in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Shan-Ying Wu; Sheng-Hui Lan; Hsiao-Sheng Liu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

4.  Mitophagy Controls the Activities of Tumor Suppressor p53 to Regulate Hepatic Cancer Stem Cells.

Authors:  Kai Liu; Jiyoung Lee; Ja Yeon Kim; Linya Wang; Yongjun Tian; Stephanie T Chan; Cecilia Cho; Keigo Machida; Dexi Chen; Jing-Hsiung James Ou
Journal:  Mol Cell       Date:  2017-10-12       Impact factor: 17.970

5.  Autophagy and mitophagy in hepatocarcinogenesis.

Authors:  Kai Liu; Jiyoung Lee; Jing-Hsiung James Ou
Journal:  Mol Cell Oncol       Date:  2018-01-23

6.  Reciprocal antagonism between the netrin-1 receptor uncoordinated-phenotype-5A (UNC5A) and the hepatitis C virus.

Authors:  M-L Plissonnier; T Lahlali; M Raab; M Michelet; C Romero-López; M Rivoire; K Strebhardt; D Durantel; M Levrero; P Mehlen; F Zoulim; R Parent
Journal:  Oncogene       Date:  2017-08-07       Impact factor: 9.867

Review 7.  Autophagy, a double-edged sword in anti-angiogenesis therapy.

Authors:  Jiatao Liu; Lulu Fan; Hua Wang; Guoping Sun
Journal:  Med Oncol       Date:  2015-12-29       Impact factor: 3.064

Review 8.  New insights into autophagy in hepatocellular carcinoma: mechanisms and therapeutic strategies.

Authors:  Shuo Yang; Liang Yang; Xinyu Li; Bowen Li; Yan Li; Xiaodong Zhang; Yingbo Ma; Xueqiang Peng; Hongyuan Jin; Hangyu Li
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

9.  RNA Binding Protein HuR Promotes Autophagosome Formation by Regulating Expression of Autophagy-Related Proteins 5, 12, and 16 in Human Hepatocellular Carcinoma Cells.

Authors:  Eunbyul Ji; Chongtae Kim; Hoin Kang; Sojin Ahn; Myeongwoo Jung; Youlim Hong; Hyosun Tak; Sukchan Lee; Wook Kim; Eun Kyung Lee
Journal:  Mol Cell Biol       Date:  2019-03-01       Impact factor: 4.272

10.  Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2).

Authors:  Lin Jiao; Hai-Liang Zhang; Dan-Dan Li; Ke-Li Yang; Jun Tang; Xuan Li; Jiao Ji; Yan Yu; Rui-Yan Wu; Senthilkumar Ravichandran; Jian-Jun Liu; Gong-Kan Feng; Min-Shan Chen; Yi-Xin Zeng; Rong Deng; Xiao-Feng Zhu
Journal:  Autophagy       Date:  2017-12-17       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.